- Investopedia•4 days ago
Prima is running trials to treat breast cancer and skin cancer using combinations of its drug IMP321.
- Marketwired•8 days ago
Prima BioMed Ltd , is pleased to announce that its French subsidiary, Immutep S.A.S., has received EUR 618,307 in payment of a research tax credit from the French state under the Crédit d'Impôt Recherche ...
- The Wall Street Journal•19 days ago
Major shareholders, including Singapore state investment firm Temasek Holdings, are planning to sell their stake in an Indonesian retailer in a deal that could value the company at as much as $1 billion....
PRR.AX : Summary for PRIMA FPO - Yahoo Finance
Prima Biomed Ltd. (PRR.AX)
ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
|Day's Range||0.03 - 0.03|
|52 Week Range||0.03 - 0.05|
|PE Ratio (TTM)||-1.21|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|